Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new version of the page's documentation. This change does not modify the public content or user-facing features.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe study’s listed results/measurement section has been updated, including endpoint time frames and the detailed wording of response and survival measures for cohorts 1–8 and cohort 9. It also reflects newer results posting/submission dates and study-document metadata updates rather than new study design elements like interventions, eligibility, or locations.SummaryDifference3%

- Check71 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check85 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check92 days agoChange DetectedThe status changed from 'No Results Posted' to 'Results Submitted', indicating that results are being prepared/uploaded for the study record.SummaryDifference0.0%

- Check107 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.